Dr. Bembenek brings decades of global leadership experience in healthcare marketing, strategy and product development, and commercialization.
Peerbridge Health announces the appointment of Tamanna Bembenek, PhD, to the Peerbridge Health Board of Directors. Dr. Bembenek brings decades of global leadership experience in healthcare marketing, strategy and product development, and commercialization.
“We are thrilled to welcome Tamanna to Peerbridge’s Board of Directors,” said Adrian Gilmore, CEO and President at Peerbridge Health. “Her expertise across global healthcare markets will enhance our efforts to innovate and drive meaningful outcome improvements for physicians and their patients.”
Dr. Bembenek has served as a senior healthcare executive for both Royal Phillips and GE Healthcare. Most recently, she served as the Senior Vice President of Marketing of Health-tech business groups at Royal Philips.
Before joining Philips, Dr. Bembenek spent more than a decade as a marketing leader in Diagnostic Imaging at GE Healthcare, including global leadership positions in PET/SPECT and CT imaging for neurological applications, and global point-of-care ultrasound marketing and product management.
Dr. Bembenek earned a bachelor of art from Lake Forest College and a PhD in biochemistry from the Texas A&M University’s Health Science Center.
About Peerbridge Health
Peerbridge Health™ is a digital health company with a focus on advancing the diagnosis and treatment of heart disease. Peerbridge is committed to ensuring the greatest care is extended to those who rely on our products and ECG reporting services. The company holds several pioneering patents incorporating multiple on-body sensors that communicate vital sign information via a single transmitter. For more information, visit peerbridgehealth.com.